A 31-year-old woman with epilepsy in Seattle dies after taking actions based on advice she received from ChatGPT to change how she takes her life-sustaining medication. Her condition worsens after she microdoses or tapers her epilepsy treatment, and she later dies.

Both reports describe her consulting ChatGPT shortly before her death and her parents providing the basic timeline. The differing emphasis is on how the advice was framed: one outlet highlights microdosing and portrays it as directly prompting medication dosage changes, while the other focuses on advice to decrease or taper the medication and cites her question to ChatGPT about reducing it.

Together, the articles present the same core account—self-adjustment of epilepsy medication after seeking guidance from an AI chatbot—and differ mainly in the phrasing used to describe the medication change and the lead emphasis on “microdosing” versus “tapering off.”